Aging brain immune cells fuel Alzheimer’s progression

These cells are called microglia. They are the brain’s resident immune system. In a young brain they maintain a healthy balance, shifting between a defensive mode and a quieter, tissue-maintenance mode. With age, that balance breaks down. Microglia get stuck in an inflammatory state and start releasing signals that damage surrounding brain tissue.

That is harmful on its own. But the researchers behind this review show a direct link to Alzheimer’s disease. The molecular changes microglia undergo during normal aging overlap significantly with patterns seen in Alzheimer’s patients. Why some people develop dementia and others do not remains unclear.

Oxidative stress and cellular senescence

The review, published in the journal Cells, highlights two processes that drive the chronic inflammatory state in microglia. The first is oxidative stress: damage caused by reactive oxygen molecules (free radicals) that accumulate in older cells. The second is cellular senescence, in which cells stop dividing but remain active and continue releasing inflammatory signals.

Together, these processes impair microglia’s core function: clearing protein aggregates such as amyloid and tau, both hallmarks of Alzheimer’s. Instead of clearing them, aging microglia may amplify the damage.

Microglia as a therapeutic target

This makes microglia a promising target for future therapies. The review discusses strategies aimed at reversing the inflammatory state, including interventions in signaling pathways that drive senescence. These remain preliminary directions rather than proven treatments. But for those thinking about tackling Alzheimer’s through aging mechanisms, this represents a relevant piece of the puzzle.

The key question now is whether microglia in humans respond the same way as in animal models, and whether interventions can come early enough to prevent damage.

Read the original article